Business news

    VIDEO: Imugene soared 10.5% after announcing a new clinical trial supply agreement with Roche

    Video thumbnail
    Video Player is loading.
    Current Time 0:13
    Duration 1:09
    Loaded: 80.96%
    Stream Type LIVE
    Remaining Time 0:56
     
    1x
      • Chapters
      • descriptions off, selected
      • captions off, selected
      • default, selected

      The Australian market ended Friday?s session with a sharp afternoon rally to end a four day losing streak. The ASX200 closed 2.19% higher at 6988.10 points, boosted by a surge in consumer staples stocks.

      The stocks that made headlines today were:

      Imugene jumped 10.5% today after the biotech company announced it has entered into a clinical trial supply agreement with Swiss multinational healthcare company Roche for a period of up to 5-years.

      Pure Hydrogen soared 29% today after the hydrogen and clean energy producer announced H2X Global, a company that Pure Hydrogen holds the largest interest in, has entered into a joint venture with Advik Hi-Tech in India to build hydrogen powered fuel cells, generators and vehicles for use in India.

      Shares in surface chemistry company AnteoTech crashed 29% today after the company released an update on its EuGeni Reader and COVID-19 Rapid Diagnostic Test, saying that the TGA has requested further clinical data and information to meet the clinical data requirements.

      Disclaimer

      Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relates to your unique circumstances. Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of, or reliance on the information provided directly or indirectly by use of this platform.

      Publisher
      Grafa